JP2022545655A5 - - Google Patents
Info
- Publication number
- JP2022545655A5 JP2022545655A5 JP2022510108A JP2022510108A JP2022545655A5 JP 2022545655 A5 JP2022545655 A5 JP 2022545655A5 JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022510108 A JP2022510108 A JP 2022510108A JP 2022545655 A5 JP2022545655 A5 JP 2022545655A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence number
- sequence
- amino acid
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888475P | 2019-08-17 | 2019-08-17 | |
| US62/888,475 | 2019-08-17 | ||
| US201962888702P | 2019-08-19 | 2019-08-19 | |
| US62/888,702 | 2019-08-19 | ||
| PCT/US2020/046335 WO2021034646A1 (en) | 2019-08-17 | 2020-08-14 | Multimeric bispecific anti-cd123 binding molecules and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545655A JP2022545655A (ja) | 2022-10-28 |
| JP2022545655A5 true JP2022545655A5 (https=) | 2023-06-16 |
| JP7585305B2 JP7585305B2 (ja) | 2024-11-18 |
Family
ID=74659605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510108A Active JP7585305B2 (ja) | 2019-08-17 | 2020-08-14 | 多量体の二重特異性抗ｃｄ１２３結合分子及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220289856A1 (https=) |
| EP (1) | EP4013796A4 (https=) |
| JP (1) | JP7585305B2 (https=) |
| KR (1) | KR20220045030A (https=) |
| CN (1) | CN114341179B (https=) |
| AU (1) | AU2020334882A1 (https=) |
| CA (1) | CA3147767A1 (https=) |
| IL (1) | IL289964A (https=) |
| MX (1) | MX2022002024A (https=) |
| WO (1) | WO2021034646A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3560954T3 (pl) | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| WO2016154593A1 (en) | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| EP3355913B1 (en) | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| MX2021014973A (es) | 2019-06-07 | 2022-04-18 | Adimab Llc | Anticuerpos anti-cd3 de alta afinidad y metodos para su generacion y uso. |
| US20240076392A1 (en) * | 2021-02-17 | 2024-03-07 | Igm Biosciences, Inc. | Anti-cd123 binding molecules and uses thereof |
| WO2022212191A1 (en) * | 2021-04-01 | 2022-10-06 | Modernatx, Inc. | Mucosal expression of antibody structures and isotypes by mrna |
| JP2024530465A (ja) * | 2021-08-06 | 2024-08-21 | ウニバズィテート バーゼル | 細胞療法に使用するための識別可能な細胞表面タンパク質変異体 |
| EP4377360A4 (en) * | 2021-09-17 | 2025-10-15 | Adimab Llc | Anti-cd3 antibodies |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6045774A (en) * | 1997-01-10 | 2000-04-04 | Epicyte Pharmaceutical Inc. | J chain polypeptide targeting molecule linked to an imaging agent |
| PT3444271T (pt) * | 2013-08-08 | 2022-01-05 | Inst Nat Sante Rech Med | Modulocinas baseadas em il-15 e no domínio sushi de il-15ralfa |
| PL3560954T3 (pl) * | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| US10259887B2 (en) * | 2014-11-26 | 2019-04-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
| CN120988137A (zh) * | 2015-01-23 | 2025-11-21 | 赛诺菲 | 抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体 |
| EP3355913B1 (en) * | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| EP3356401B1 (en) * | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| WO2017210443A1 (en) * | 2016-06-01 | 2017-12-07 | Xencor, Inc. | Bispecific antibodies that bind cd123 and cd3 |
| MX2019011986A (es) * | 2017-04-07 | 2019-11-07 | Igm Biosciences Inc | Regiones constantes de igm humana modificadas para la modulacion de la funcion efectora de la citolisis dependiente de complemento referencia cruzada a solicitudes relacionadas. |
| CN118894936A (zh) * | 2017-05-08 | 2024-11-05 | 阿迪马布有限责任公司 | 抗cd3结合结构域和包含它们的抗体以及它们的产生及使用方法 |
| CN108409840B (zh) * | 2017-05-18 | 2020-06-23 | 重庆精准生物技术有限公司 | 抗cd123单链抗体及其组合的嵌合抗原受体和应用 |
| MX2020009069A (es) * | 2018-03-01 | 2020-10-08 | Igm Biosciences Inc | Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero. |
-
2020
- 2020-08-14 KR KR1020227008406A patent/KR20220045030A/ko active Pending
- 2020-08-14 MX MX2022002024A patent/MX2022002024A/es unknown
- 2020-08-14 JP JP2022510108A patent/JP7585305B2/ja active Active
- 2020-08-14 CA CA3147767A patent/CA3147767A1/en active Pending
- 2020-08-14 CN CN202080058040.5A patent/CN114341179B/zh active Active
- 2020-08-14 US US17/635,490 patent/US20220289856A1/en active Pending
- 2020-08-14 EP EP20855479.0A patent/EP4013796A4/en active Pending
- 2020-08-14 WO PCT/US2020/046335 patent/WO2021034646A1/en not_active Ceased
- 2020-08-14 AU AU2020334882A patent/AU2020334882A1/en active Pending
-
2022
- 2022-01-19 IL IL289964A patent/IL289964A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545655A5 (https=) | ||
| JP7551693B2 (ja) | ＮＫｐ４６結合タンパク質の可変領域 | |
| US12448423B2 (en) | Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains | |
| CN113874399B (zh) | 抗ror1/抗cd3双特异性结合分子 | |
| JP6702893B2 (ja) | 多重特異的抗原結合タンパク質 | |
| JP2022177090A5 (https=) | ||
| US20210253736A1 (en) | Heterodimeric antibodies that bind fibroblast activation protein | |
| JP2019530640A5 (https=) | ||
| CN112867734A (zh) | 包含IL-15/IL-15Ra Fc融合蛋白和PD-1抗原结合结构域的靶向PD-1的异源二聚体融合蛋白及其用途 | |
| US20240199750A1 (en) | Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging | |
| JP2019528683A5 (https=) | ||
| JP2018524326A (ja) | 多重特異的ｎｋエンゲイジャータンパク質 | |
| JP2021510736A5 (https=) | ||
| JP2018508214A5 (https=) | ||
| GB2519786A (en) | Multivalent antigen-binding protein molecules | |
| AU2020334882A1 (en) | Multimeric bispecific anti-CD123 binding molecules and uses thereof | |
| JP2022549186A5 (https=) | ||
| JP2020536969A (ja) | Ｃｄ３結合タンパク質の投薬レジメン | |
| CN117616050A (zh) | 与nkp46、细胞因子受体、肿瘤抗原和cd16a结合的多特异性蛋白质 | |
| Acheampong | Bispecific antibody (bsAb) construct formats and their application in cancer therapy | |
| WO2021231976A1 (en) | Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3 | |
| JP2025506341A5 (https=) | ||
| JP2025511135A5 (https=) | ||
| AU2024331754A1 (en) | Anti-cd20 x anti-cd28 combination therapies | |
| WO2025045018A1 (en) | Anti-gamma delta tcr antibodies and uses thereof |